First vaccine against COVID-19 in Latin America.
Anti-COVID-19 vaccine candidate, nasal application.
Interferon alfa 2b for nasal application for the prophylaxis of SARS-CoV-2 virus infection.
Jusvinza controls hyperinflammation, regulates the immune response and reduces the risk of mortality
Combination of interferon alpha 2b and gamma for basal cell carcinoma.
Antiviral, antiproliferative and immunomodulatory.
Contains transfer factor to treat cellular immunodeficiency, cancer, and other diseases.